• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌的调强放射治疗:剂量学和临床结果

Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results.

作者信息

Bae Sun Hyun, Jang Won Il, Park Hee Chul

机构信息

Department of Radiation Oncology, Soonchunhyang University College of Medicine, Bucheon, Korea.

Department of Radiation Oncology, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.

出版信息

Oncotarget. 2017 Jul 13;8(35):59965-59976. doi: 10.18632/oncotarget.19219. eCollection 2017 Aug 29.

DOI:10.18632/oncotarget.19219
PMID:28938697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5601793/
Abstract

Since the introduction of 3-dimensional conformal radiotherapy (3DCRT), new radiotherapy techniques have expanded the indication of radiotherapy for the treatment of hepatocellular carcinoma (HCC), from the hitherto palliative to a now curative-intent purpose. Intensity-modulated radiotherapy (IMRT), currently the most advanced radiotherapy technique, is considered an attractive option for the treatment of HCC, and is more widely applied because it can deliver a higher dose to the tumor than 3DCRT while sparing surrounding normal organs. However, the advantages and potential disadvantages of IMRT for treating HCC have not been fully established. This article deals with three different IMRT techniques, including static IMRT and volumetric modulated arc therapy using conventional multileaf collimator (MLC) mounted linear accelerators, and helical IMRT using binary MLC mounted helical tomotherapy machine. We review dosimetric and clinical studies for these IMRT techniques for the treatment of HCC.

摘要

自从三维适形放疗(3DCRT)问世以来,新的放疗技术已将肝细胞癌(HCC)放疗的适应证从以往的姑息性治疗扩展到目前的根治性治疗目的。调强放疗(IMRT)是目前最先进的放疗技术,被认为是治疗HCC的一个有吸引力的选择,并且因其能比3DCRT向肿瘤输送更高剂量的同时保护周围正常器官而得到更广泛的应用。然而,IMRT治疗HCC的优势和潜在劣势尚未完全明确。本文探讨三种不同的IMRT技术,包括使用传统多叶准直器(MLC)的静态IMRT和容积调强弧形放疗,以及使用二元MLC的螺旋断层放疗机进行的螺旋IMRT。我们回顾了这些IMRT技术治疗HCC的剂量学和临床研究。

相似文献

1
Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results.肝细胞癌的调强放射治疗:剂量学和临床结果
Oncotarget. 2017 Jul 13;8(35):59965-59976. doi: 10.18632/oncotarget.19219. eCollection 2017 Aug 29.
2
Superiority of helical tomotherapy on liver sparing and dose escalation in hepatocellular carcinoma: a comparison study of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy.螺旋断层放疗在肝细胞癌肝脏保护和剂量递增方面的优势:三维适形放疗与调强放疗的比较研究
Onco Targets Ther. 2016 Jun 24;9:3807-13. doi: 10.2147/OTT.S106869. eCollection 2016.
3
Integral dose in three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy.三维适形放疗、调强放疗和螺旋断层放疗中的积分剂量。
Clin Oncol (R Coll Radiol). 2009 Nov;21(9):706-12. doi: 10.1016/j.clon.2009.08.002. Epub 2009 Aug 27.
4
Dosimetric comparison of left-sided whole-breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and volumetric arc therapy.左侧全乳照射采用三维适形放疗、正向计划调强放疗、逆向计划调强放疗、螺旋断层放疗和容积弧形调强放疗的剂量学比较。
Phys Med. 2015 Jun;31(4):360-7. doi: 10.1016/j.ejmp.2015.02.005. Epub 2015 Feb 26.
5
Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer.多叶准直器叶片宽度对头颈部癌症调强放疗的剂量学影响。
Med Phys. 2014 Feb;41(2):021712. doi: 10.1118/1.4860155.
6
Dosimetric comparisons of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and helical tomotherapy in whole abdominopelvic radiotherapy for gynecologic malignancy.三维适形放疗、调强放疗和螺旋断层放疗在妇科恶性肿瘤全腹盆腔放疗中的剂量学比较
Technol Cancer Res Treat. 2009 Oct;8(5):369-77. doi: 10.1177/153303460900800507.
7
Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).单弧容积调强弧形放疗(sVMAT)作为胃癌辅助治疗:与三维适形放疗(3D-CRT)和调强放疗(IMRT)的剂量学比较
Med Dosim. 2013 Winter;38(4):395-400. doi: 10.1016/j.meddos.2013.04.007. Epub 2013 Jun 20.
8
Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.鼻咽癌调强放射治疗(IMRT)技术的比较
Int J Cancer. 2001 Apr 20;96(2):126-31. doi: 10.1002/ijc.1004.
9
Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.螺旋断层放疗、调强放射治疗、容积调强弧形放疗及三维适形放疗治疗T1N0声门癌的剂量学比较
Med Dosim. 2016;41(4):329-333. doi: 10.1016/j.meddos.2016.08.002. Epub 2016 Oct 17.
10
Advances in treatment techniques: arc-based and other intensity modulated therapies.治疗技术的进展:基于弧形和其他强度调制疗法。
Cancer J. 2011 May-Jun;17(3):166-76. doi: 10.1097/PPO.0b013e31821f8318.

引用本文的文献

1
Establishment of a prognosis-related predictive model for hepatocellular carcinoma patients with macrovascular invasion treated with transcatheter arterial chemoembolization combined with intensity modulated radiotherapy.建立经动脉化疗栓塞联合调强放疗治疗的伴有大血管侵犯的肝细胞癌患者的预后相关预测模型。
Transl Cancer Res. 2025 Feb 28;14(2):1214-1222. doi: 10.21037/tcr-24-1226. Epub 2025 Feb 24.
2
Radiation and Immune Checkpoint Inhibitors: Combination Therapy for Treatment of Hepatocellular Carcinoma.放疗与免疫检查点抑制剂:联合治疗肝癌。
Int J Mol Sci. 2023 Nov 26;24(23):16773. doi: 10.3390/ijms242316773.
3
The Current Evidence of Intensity-Modulated Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.肝细胞癌调强放射治疗的当前证据:一项系统评价和荟萃分析
Cancers (Basel). 2023 Oct 10;15(20):4914. doi: 10.3390/cancers15204914.
4
Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma.肝细胞癌患者单纯非手术局部区域治疗或联合全身治疗
Cancers (Basel). 2023 Mar 14;15(6):1748. doi: 10.3390/cancers15061748.
5
The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy.α-RECIST(RECIST 1.1联合甲胎蛋白):一种用于在肝切除术前识别不可切除肝细胞癌转化放疗肿瘤反应的新工具。
Front Oncol. 2022 May 24;12:905260. doi: 10.3389/fonc.2022.905260. eCollection 2022.
6
Treatment outcomes of helical tomotherapy for hepatocellular carcinoma in terms of intermediate-dose spillage.螺旋断层放疗对肝细胞癌的治疗效果:关于中等剂量溢出情况
Transl Cancer Res. 2021 Mar;10(3):1420-1429. doi: 10.21037/tcr-20-2912.
7
Recent update on comprehensive therapy for advanced hepatocellular carcinoma.晚期肝细胞癌综合治疗的最新进展
World J Gastrointest Oncol. 2021 Aug 15;13(8):845-855. doi: 10.4251/wjgo.v13.i8.845.
8
The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.根治性切除术后微血管侵犯的肝细胞癌患者几种术后辅助治疗的效果:一项系统评价和荟萃分析
Cancer Cell Int. 2021 Feb 6;21(1):92. doi: 10.1186/s12935-021-01790-6.
9
Stereotactic Body Radiotherapy Based on Tc-GSA SPECT Image-guided Inverse Planning for Hepatocellular Carcinoma.基于 Tc-GSA SPECT 图像引导逆向计划的立体定向体部放射治疗肝癌。
In Vivo. 2020 Nov-Dec;34(6):3583-3588. doi: 10.21873/invivo.12202.
10
Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis.质子与光子放疗治疗原发性肝细胞癌:倾向评分匹配分析。
Radiat Oncol. 2020 Jun 30;15(1):159. doi: 10.1186/s13014-020-01605-4.

本文引用的文献

1
Pre-radiotherapy neutrophil-to-lymphocyte ratio as an independent prognostic factor in patients with locally advanced hepatocellular carcinoma treated with radiotherapy.放疗前中性粒细胞与淋巴细胞比值作为局部晚期肝细胞癌放疗患者的独立预后因素
Oncotarget. 2017 Mar 7;8(10):16964-16971. doi: 10.18632/oncotarget.15209.
2
Clinical benefits of new immobilization system for hypofractionated radiotherapy of intrahepatic hepatocellular carcinoma by helical tomotherapy.新型固定系统在肝内肝细胞癌螺旋断层放疗中进行大分割放疗的临床益处
Med Dosim. 2017;42(1):37-41. doi: 10.1016/j.meddos.2016.10.005. Epub 2017 Jan 23.
3
Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.在人肝癌荷瘤小鼠模型中,索拉非尼预处理通过靶向MEK/ERK/NF-κB通路增强放疗效果。
Oncotarget. 2016 Dec 20;7(51):85450-85463. doi: 10.18632/oncotarget.13398.
4
Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines.放射治疗在当前肝细胞癌临床实践指南中的应用
Radiat Oncol J. 2016 Sep;34(3):160-167. doi: 10.3857/roj.2016.01970. Epub 2016 Sep 28.
5
Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016.门静脉癌栓型肝细胞癌的管理:2016年回顾与更新
World J Gastroenterol. 2016 Aug 28;22(32):7289-300. doi: 10.3748/wjg.v22.i32.7289.
6
Therapeutic Strategies in HCC: Radiation Modalities.肝癌的治疗策略:放疗方式
Biomed Res Int. 2016;2016:1295329. doi: 10.1155/2016/1295329. Epub 2016 Aug 3.
7
The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy.肝细胞癌门静脉或肝静脉血栓形成对放射治疗的反应
Radiat Oncol J. 2016 Sep;34(3):168-176. doi: 10.3857/roj.2016.01669. Epub 2016 Aug 22.
8
Liver-Directed Radiotherapy for Hepatocellular Carcinoma.肝细胞癌的肝靶向放疗
Liver Cancer. 2016 Jul;5(3):198-209. doi: 10.1159/000367764. Epub 2016 May 10.
9
The clinical utilization of radiation therapy in Korea between 2009 and 2013.2009年至2013年韩国放射治疗的临床应用情况。
Radiat Oncol J. 2016 Jun;34(2):88-95. doi: 10.3857/roj.2016.01753. Epub 2016 Jun 30.
10
Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.肝细胞癌的放射治疗:新适应症及未来研究方向
J Natl Cancer Inst. 2016 Jul 4;108(9). doi: 10.1093/jnci/djw133. Print 2016 Sep.